Pfizer’s clinical trial data for its vaccine shows that one out of five children will develop severe fevers.
In the latest report from Unreported Truths, Alex Berenson emphasized the terrible data shared by Pfizer and their investor.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The company wants to find the dose for young children. Here’s a hint for Pfizer: children don’t need these vaccines.
Check this out:
Severe fevers in kids: Troubling data about Pfizer’s Covid vaccine and children… from Pfizer’s own clinical trial https://t.co/lJQ0EDY9Y8
— Vicki McKenna (@VickiMcKenna) January 4, 2022
Pfizer’s vaccine shows dose-related side effects in children; still, the company is letting five-year-olds receive an mRNA dosage that caused serious fevers in slightly younger kids.https://t.co/T0Yy6GL4At
— Andrew Bostom, MD, MS (@andrewbostom) January 4, 2022
20% of kids had severe fever from Pfizer jab… from Pfizer’s own clinical trial. Don’t experiment on your kids. https://t.co/YWpy1SiQ0i
— Mainely Free (@MaineLogic) January 4, 2022
Some young children had serious fevers after receiving a medium-sized dose of Pfizer’s mRNA Covid vaccine, a Pfizer clinical trial found.https://t.co/0kPQ9rDgPd
— Died Suddenly & Unexpectedly (@diedsuddenly) January 4, 2022
Fevers in kids 2-5 who received 10 micrograms of mRNA were both more common and more severe than those in other children tested with the vaccine, the company found. The side effect occurred after both the first and second vaccine dose.
Pfizer can’t make an advance with the 10-microgram two-dose regimen for children at the age of 2-5; the company allowed the shots for five and older.
Pfizer tests much smaller doses for young children: three micrograms.
If a child of 5 develops as 4 or 3, takes the vaccine dose for kids at 5, they will develop a severe fever.
Check this slideshow presentation:
Additionally, “Pfizer has not published any safety or efficacy data for its vaccine in children under 5 in a peer-reviewed journal,” reports the former New York Times journalist.
In their update, Pfizer said it would amend the study to evaluate a 3-microgram dose for children aged 6-months to 5-years-old.
Pfizer’s press release also admitted the company’s going on to test a third jab of the 3-microgram dose in children aged 2-5 after failing non-inferiority trials, further illustrating dosing challenges.
“Pfizer has not published any safety or efficacy data for its vaccine in children under 5 in a peer-reviewed journal,” Berenson notes, which means parents unfortunately have to trust data from the very company producing the vaccine.
Children must’s get vaccinated!
Parents, you have to protect your kids!